Acutely Decompensated Heart Failure with Preserved and Reduced Ejection Fraction Present with Comparable Haemodynamic Congestion
Lucas Van Aelst(KU Leuven), Marie‐France Seronde(Centre Hospitalier Universitaire de Besançon), Patrick Rossignol(Inserm), Faı̈ez Zannad(Centre d’Investigation Clinique Innovation Technologique de Nancy), Rui Plácido(Inserm), Mattia Arrigo(University Hospital of Zurich), Malha Sadoune(Inserm), Marc Badoz(Centre Hospitalier Universitaire de Besançon), Carolyn S.P. Lam(University of Glasgow), Étienne Gayat(Inserm), Alain Cohen‐Solal(Inserm), Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Jean‐Marie Launay(Université Claude Bernard Lyon 1), Nicolas Girerd(Université de Lorraine), Philippe Manivet(Inserm), Eiichi Akiyama(Kumamoto University)
Cited by 156
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k